Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Semenogelin I (SEMG1) (Middle Region) Peptide

SEMG1 Reactivité: Humain Hôte: Synthetic BP, WB
N° du produit ABIN983528

Aperçu rapide pour Semenogelin I (SEMG1) (Middle Region) Peptide (ABIN983528)

Antigène

SEMG1 (Semenogelin I (SEMG1))

Origine

Humain

Source

  • 5
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    Middle Region

    Attributs du produit

    This is a synthetic peptide designed for use in combination with anti-SEMG1 antibody (Catalog #: ARP42089_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Purification

    Purified
  • Indications d'application

    Each Investigator should determine their own optimal working dilution for specific applications.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Concentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Conseil sur la manipulation

    Avoid repeated freeze-thaw cycles.

    Stock

    -20 °C

    Stockage commentaire

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Antigène

    SEMG1 (Semenogelin I (SEMG1))

    Sujet

    SEMG1 is the predominant protein in semen. The secreted protein is involved in the formation of a gel matrix that encases ejaculated spermatozoa. The prostate-specific antigen (PSA) protease processes this protein into smaller peptides, with each possibly

    Alias Symbols: MGC14719, SEMG, SGI, CT103, dJ172H20.2

    Protein Interaction Partner: KLK2,KLK3,PRKCA,SEMG2,TGM1,UBQLN4,SEMG2

    Protein Size: 402

    Poids moléculaire

    40 kDa

    ID gène

    6406

    NCBI Accession

    NM_198139, NP_937782
Vous êtes ici:
Chat with us!